1. Home
  2. CIX vs PLYX Comparison

CIX vs PLYX Comparison

Compare CIX & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

HOLD

Current Price

$25.90

Market Cap

291.7M

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$2.28

Market Cap

271.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CIX
PLYX
Founded
1993
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.7M
271.8M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
CIX
PLYX
Price
$25.90
$2.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
2.8K
340.6K
Earning Date
05-05-2026
05-22-2026
Dividend Yield
9.48%
N/A
EPS Growth
17.04
N/A
EPS
0.48
N/A
Revenue
$158,285,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$53.96
N/A
Revenue Growth
8.46
N/A
52 Week Low
$20.29
$2.01
52 Week High
$32.30
$9.18

Technical Indicators

Market Signals
Indicator
CIX
PLYX
Relative Strength Index (RSI) 62.42 36.43
Support Level $23.17 N/A
Resistance Level $25.90 $3.41
Average True Range (ATR) 0.70 0.56
MACD 0.08 0.01
Stochastic Oscillator 87.14 12.30

Price Performance

Historical Comparison
CIX
PLYX

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's reportable operating segment includes Security Products and Marine Components. It generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.

Share on Social Networks: